GlassScriptPhysician profile
Denise K Petersen
NPI 1386663805
$3,506.87
in general payments reported to CMS, 2019-2025
19 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $742 · 2023: $864 · 2024: $718 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,106 · Travel and Lodging: $313 · Consulting Fee: $281 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.94 |
| Travel and Lodging | $312.94 |
| Consulting Fee | $281.25 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,474.79 | 2022-2025 | Cardiomems |
| Astrazeneca Pharmaceuticals LP | $311.85 | 2024-2025 | Lokelma, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.67 | 2022-2024 | Jardiance |
| Abiomed | $223.11 | 2022-2024 | Impella |
| Scpharmaceuticals INC. | $199.75 | 2023-2024 | |
| Pfizer INC. | $139.88 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $108.08 | 2022-2025 | Eliquis, Camzyos |
| Endotronix, INC. | $102.09 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Novartis Pharmaceuticals Corporation | $94.67 | 2022-2024 | |
| Novo Nordisk INC | $81.52 | 2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.82 | 2023-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $65.85 | 2022-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $61.04 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $43.24 | 2025 | Attruby |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $39.81 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $37.98 | 2024 | Arcalyst |
| Boston Scientific Corporation | $34.42 | 2023 | Vigilant X4 Crt-D |
| Edwards Lifesciences Corporation | $19.30 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.